Clinical trial
Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent…
NCT00131235 · Tampere University, Other · Active, not recruiting
Key facts
| NCT number | NCT00131235 |
|---|---|
| Title | Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth |
| Official title | Lungwena Antenatal Intervention Study. A Single-centre Intervention Trial in Rural Malawi, Testing Maternal and Infant Health Effects of Presumptive Intermittent Treatment of Pregnant Women With Sulfadoxine-pyrimethamine and Azithromycin |
| Lead sponsor | Tampere University, Other |
| Collaborators | Academy of Finland Foundation for Paediatric Research, Finland |
| Status | Active, not recruiting |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Malaria, Sexually Transmitted Diseases, Preterm Birth, Pregnancy |
| Intervention type | Drug |
| Interventions | Sulfadoxine-pyrimethamine treatment twice during pregnancy, Sulfadoxine-pyrimethamine at 4-week intervals, Sulfadoxine-pyrimethamine every 4 weeks + azithromycin twice |
| Enrollment | 1,320 |
| Start date | Dec 1, 2003 |
| Primary completion | Jun 1, 2007 |
| Completion | Dec 31, 2027 |
| First posted | Aug 17, 2005 |
| Last update posted | Mar 25, 2025 |
| Countries | Malawi |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: